Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Oxacalcitriol")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 34

  • Page / 2
Export

Selection :

  • and

Adsorption of oxacalcitriol by polysulphone haemodialyser in patients with secondary hyperparathyroidismTSURUOKA, Shuichi; YAMAMOTO, Hisashi; IOKA, Takashi et al.British journal of clinical pharmacology. 2004, Vol 58, Num 5, pp 488-495, issn 0306-5251, 8 p.Article

Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytesKAMIMURA, S; GALLIENI, M; KUBODERA, N et al.Endocrinology (Philadelphia). 1993, Vol 133, Num 6, pp 2719-2723, issn 0013-7227Article

Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolismFINCH, J. L; BROWN, A. J; KUBODERA, N et al.Kidney international. 1993, Vol 43, Num 3, pp 561-566, issn 0085-2538Conference Paper

Effect of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patientsDOI, Shigehiro; YORIOKA, Noriaki; USUI, Koji et al.Internal medicine (Tokyo. 1992). 2003, Vol 42, Num 10, pp 955-959, issn 0918-2918, 5 p.Article

Determination of 22-oxacalcitriol, a new analog of 1α, 25-dihydroxyvitamin D3, in human serum by liquid chromatography-mass spectrometryISHIGAI, M; ASOH, Y; KUMAKI, K et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 706, Num 2, pp 261-267, issn 1387-2273Article

Radioimmunoassay method for the determination of 22-oxacalcitriol, a novel analog of 1α,25-dihydroxyvitamin D3 having valuable clinical potency, in rat and human plasmaKOBAYASHI, N; SHIMADA, K; TAKI, H et al.Biological & pharmaceutical bulletin. 1995, Vol 18, Num 3, pp 382-387, issn 0918-6158Article

22-Oxacalcitriol suppresses 25-hydroxycholecalciferol-1α-hydroxylase in rat kidneyGRIEFF, M; DUSSO, A; MORI, T et al.Biochemical and biophysical research communications (Print). 1992, Vol 185, Num 1, pp 191-196, issn 0006-291XArticle

22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritisHIRATA, M; KATSUMATA, K; MASAKI, T et al.Kidney international. 1999, Vol 56, Num 6, pp 2040-2047, issn 0085-2538Article

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestineBROWN, A. J; FINCH, J; GRIEFF, M et al.Endocrinology (Philadelphia). 1993, Vol 133, Num 3, pp 1158-1164, issn 0013-7227Article

Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expressionTALLY NAVEH-MANY; SILVER, J.Endocrinology (Philadelphia). 1993, Vol 133, Num 6, pp 2724-2728, issn 0013-7227Article

The activity of 22-oxacalcitrol in osteoblast-like (RFOS 17/2.8) cellsPERNALETE, N; MORI, T; NISHII, Y et al.Endocrinology (Philadelphia). 1991, Vol 129, Num 2, pp 778-784, issn 0013-7227Article

A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hyprcalcemiaJUNKO ABE; NAKANO, T; NISHII, Y et al.Endocrinology (Philadelphia). 1991, Vol 129, Num 2, pp 832-837, issn 0013-7227Article

Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathwayYAMAGUCHI, Koji; MITSUI, Tetsuya; YAMAMOTO, Toshinori et al.Pharmaceutical research. 2006, Vol 23, Num 4, pp 680-688, issn 0724-8741, 9 p.Article

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidismTSUKAMOTO, Y; HANAOKA, M; MATSUO, T et al.American journal of kidney diseases. 2000, Vol 35, Num 3, pp 458-464, issn 0272-6386Article

22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized ratsHIRATA, Michinori; MAKIBAYASHI, Kojiro; KATSUMATA, Kyoko et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, Num 12, pp 2132-2137, issn 0931-0509, 6 p.Article

Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cellsSHIIZAKI, Kazuhiro; HAYAKAWA, Naohiko; IMAZEKI, Ikuo et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 4, pp 1078-1086, issn 0931-0509, 9 p.Article

Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum : possible role in decrease of plasma 1α,25-dihydroxyvitamin D3AKENO, N; SAIKATSU, S; KIMURA, S et al.Biochemical pharmacology. 1994, Vol 48, Num 11, pp 2081-2090, issn 0006-2952Article

Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failureSANAI, Toru; TOKUMOTO, Masanori; HIRANO, Tadashi et al.The Journal of laboratory and clinical medicine. 2002, Vol 140, Num 4, pp 242-249, issn 0022-2143, 8 p.Article

In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue [3H]1,25-dihydroxy-22-oxavitamin D3 compared with [3H]1,25-dihydroxyvitamin D3, determined by micro-autoradiographyKOIKE, Nobuo; HAYAKAWA, Naohiko; TOKUDA, Kazuo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 53-57, issn 0931-0509, SUP10Conference Paper

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretionBROWN, A. J; RITTER, C. R; FINCH, J. L et al.The Journal of clinical investigation. 1989, Vol 84, Num 3, pp 728-732, issn 0021-9738Article

Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol2FAN, Stanley L.-S; SCHROEDER, Neil J; CALVERLEY, Martin J et al.Nephrology, dialysis, transplantation (Print). 2000, Vol 15, Num 12, pp 1943-1949, issn 0931-0509Article

Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male miceHALSTEAD, L. R; WEINTEIN, R. S; CHENG, S.-L et al.American journal of physiology. Endocrinology and metabolism. 1996, Vol 33, Num 1, pp E141-E147, issn 0193-1849Article

Vitamin D analogues for secondary hyperparathyroidismBROWN, Alex J; DUSSO, Adriana S; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 10-19, issn 0931-0509, SUP10Conference Paper

Advances in Research on Vitamin D and Uraemic Bone Disease: 22-Oxacalcitriol as a New Drug for Secondary Hyperparathyroidism, Hawaii, USA, 14 December 2001FUKAGAWA, Masafumi; KUROKAWA, Kiyoshi; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, issn 0931-0509, 59 p., SUP10Conference Proceedings

Effects of 1,25-dihydroxy-22-oxavitamin D3 on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidismKINUGASA, Eriko; AKIZAWA, Tadao; TAKAHASHI, Junko et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 20-27, issn 0931-0509, SUP10Conference Paper

  • Page / 2